Overview

Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the role of magnesium deficiency in the pathogenesis of decreased serum vitamin D and reduced bone density in children with chronic cholestatic liver disease.
Phase:
N/A
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborator:
Children's Hospital Medical Center, Cincinnati
Treatments:
Magnesium Sulfate